<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696472</url>
  </required_header>
  <id_info>
    <org_study_id>RoboticALH</org_study_id>
    <nct_id>NCT03696472</nct_id>
  </id_info>
  <brief_title>Robotic-assisted Left Hemicolectomy for Left Colon Cancer</brief_title>
  <acronym>RALH</acronym>
  <official_title>Robotic-assisted Left Hemicolectomy for Left Colon Cancer With a Medial-to-lateral Approach Orientated by AMA or AMV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this study is to clarify if Robotic-assisted surgery could become the
      standard approach in patients undergoing left colonic resection.

      Patient candidates to left colonic resection were randomly assigned to Robotic(RAL) or
      laparoscopic(LL) approach. The surgical staff who were not involved in the study registered
      30-day postoperative morbidity. Cost-benefit analysis was based on hospital days. Long-term
      morbidity, quality of life, and 5-year survival have also been evaluated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Robotic-assisted Left Hemicolectomy as advantages on showing the inferior mesenteric artery
      (IMA), protection of autonomic nerve compare to laparoscopic approach. Our experience found
      that operational flexibility was advantage without surgeon's position exchange.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>5-years overall survival rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short-term morbidity rate</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomosis leakage rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation Time</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss during operation</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication incident rate of surgery</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reaction protein level</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery time after surgery</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>robotic-assisted left colonic resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard left colonic resection assisted by Davinci Robotic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic left colonic resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard laparoscopic left colonic resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>robotic assisted surgery</intervention_name>
    <description>robotic assisted surgery was benefit to operation</description>
    <arm_group_label>robotic-assisted left colonic resection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic</intervention_name>
    <description>conventional laparoscopic surgery</description>
    <arm_group_label>laparoscopic left colonic resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Colon cancer adenocarcinoma The tumor located between the descending colon and the right
        1/3 of transverse colon Tumors T3,Т4а,b N0-2 Tolerance of chemotherapy ECOG 0-2

        Exclusion Criteria:

        With distant metastases Tumors T1-2 Complications of tumor Women during Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Li Chuan, M.D</last_name>
    <phone>+862368754167</phone>
    <email>lee_tran@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tang Bo, M.D</last_name>
    <phone>+86-18323479228</phone>
    <email>tangtbo@sina.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yu Peiwu, M.D/Ph.D</last_name>
      <phone>+862368754167</phone>
      <email>yupeiwu1961@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>October 5, 2018</last_update_submitted>
  <last_update_submitted_qc>October 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Li Chuan</investigator_full_name>
    <investigator_title>Secretary of General Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

